Indian Institute of Technology (IIT) Guwahati has signed a Memorandum of Understanding (MoU) with Miraclus Orthotech, to collaborate on innovative research, development, and testing of advanced orthopedic implants and instruments. The partnership aims to address critical challenges in the medical device sector and deliver high-quality, efficient solutions to improve patient care.
This partnership marks a significant milestone in advancing biomedical engineering by combining IIT Guwahati's expertise in cutting-edge research with Miraclus Orthotech's industry leadership.
The partnership will focus on four key areas:
- Research and Development: Joint efforts to design next-generation orthopedic implants and instruments.
- Product Testing and Validation: Leveraging IIT Guwahati's state-of-the-art facilities to ensure products meet global quality standards.
- Skill Development: Conducting workshops, training programs, and knowledge-sharing sessions to provide students and researchers with practical exposure to medical device technology.
- Intellectual Property Creation: Co-developing patents and publishing research outcomes to advance the field.
This partnership aims to accelerate innovation in the medical device sector, reduce reliance on imports, and enhance accessibility to affordable, high-quality healthcare solutions. By joining forces with Miraclus Orthotech, IIT Guwahati seeks to bolster India's medical device ecosystem and contribute significantly to the global healthcare landscape.
As the next step, IIT Guwahati jointly with Miraclus plans to establish a facility equipped with advanced prototyping and testing tools for orthopedic implants and instruments. This facility will serve as a hub for interdisciplinary research, bringing together experts from biomedical engineering, materials science, and clinical practice.
Additionally, the partnership will initiate industry-academia exchange programs, allowing researchers and students to work closely with industry professionals to bridge the gap between theoretical research and practical implementation. A roadmap for regulatory approvals and commercialization will also be developed to accelerate the transition of innovative medical devices from the lab to the market.